Table 2. Differences in clinical characteristics between patients of HWP and PAH.
Variable | HWP | PAH | p value |
---|---|---|---|
No. of patient | 12 | 25 | |
Age (yr) | 57.91±15.82 | 54.92±14.62 | 0.432 |
Serum PSA (ng/mL) | 2.11±1.78 | 2.44±2.49 | 0.796 |
Prostate size (mL) | 40.18±14.53 | 32.16±15.23 | 0.121 |
NIH-CPSI | |||
Sum of items 1~4 | 0.00±0.00 | 5.72±5.24 | 0.001* |
Item 5 and 6 | 2.25±3.16 | 2.28±2.26 | 0.579 |
Sum of items 7~9 | 2.25±2.89 | 4.32±2.93 | 0.023* |
Total (items 1~9) | 4.50±5.86 | 12.24±8.70 | 0.003* |
Values are presented as number only or mean±standard deviation.
PAH: prostatitis-associated hematospermia, HWP: hematospermia patients without any evidence of prostatitis, PSA: prostate-specific antigen, NIH-CPSI: National Institutes of Health Chronic Prostatitis Symptom Index.
*p<0.05.